Literature DB >> 21746941

In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases.

Mirian Domenech1, Ernesto García, Miriam Moscoso.   

Abstract

Host- and phage-coded cell wall hydrolases have been used to fight Streptococcus pneumoniae growing as planktonic cells in vitro as well as in animal models. Until now, however, the usefulness of these enzymes in biofilm-grown pneumococci has gone untested. The antipneumococcal activity of different cell wall hydrolases produced by S. pneumoniae and a number of its phages was examined in an in vitro biofilm model. The major pneumococcal autolysin LytA, an N-acetylmuramoyl-l-alanine amidase, showed the greatest efficiency in disintegrating S. pneumoniae biofilms. The phage-encoded lysozymes Cpl-1 and Cpl-7 were also very efficient. Biofilms formed by the close pneumococcal relatives Streptococcus pseudopneumoniae and Streptococcus oralis were also destroyed by the phage endolysins but not by the S. pneumoniae autolysin LytA. A cooperative effect of LytA and Cpl-1 in the disintegration of S. pneumoniae biofilms was recorded.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21746941      PMCID: PMC3165314          DOI: 10.1128/AAC.00492-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Purification of the pneumococcal N-acetylmuramyl-L-alanine amidase to biochemical homogeneity.

Authors:  J V Höltje; A Tomasz
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

2.  Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.

Authors:  Peter Sass; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

3.  Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae.

Authors:  Violeta Rodríguez-Cerrato; Pedro García; Lorena Huelves; Ernesto García; Gema Del Prado; Matilde Gracia; Carmen Ponte; Rubens López; Francisco Soriano
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

4.  Vancomycin tolerance in clinical and laboratory Streptococcus pneumoniae isolates depends on reduced enzyme activity of the major LytA autolysin or cooperation between CiaH histidine kinase and capsular polysaccharide.

Authors:  Miriam Moscoso; Mirian Domenech; Ernesto García
Journal:  Mol Microbiol       Date:  2010-06-28       Impact factor: 3.501

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The molecular characterization of the first autolytic lysozyme of Streptococcus pneumoniae reveals evolutionary mobile domains.

Authors:  P García; M Paz González; E García; J L García; R López
Journal:  Mol Microbiol       Date:  1999-07       Impact factor: 3.501

7.  In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.

Authors:  Violeta Rodríguez-Cerrato; Pedro García; Gema Del Prado; Ernesto García; Matilde Gracia; Lorena Huelves; Carmen Ponte; Rubens López; Francisco Soriano
Journal:  J Antimicrob Chemother       Date:  2007-09-07       Impact factor: 5.790

Review 8.  Novel approaches to fight Streptococcus pneumoniae.

Authors:  Beatriz Maestro; Jesús M Sanz
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2007-11

9.  Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia.

Authors:  Martin Witzenrath; Bernd Schmeck; Jan M Doehn; Thomas Tschernig; Janine Zahlten; Jutta M Loeffler; Maren Zemlin; Holger Müller; Birgitt Gutbier; Hartwig Schütte; Stefan Hippenstiel; Vincent A Fischetti; Norbert Suttorp; Simone Rosseau
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

10.  Role of the C-terminal domain of the lysozyme of Clostridium acetobutylicum ATCC 824 in a chimeric pneumococcal-clostridial cell wall lytic enzyme.

Authors:  C Croux; C Ronda; R López; J L García
Journal:  FEBS Lett       Date:  1993-12-20       Impact factor: 4.124

View more
  29 in total

Review 1.  Applying insights from biofilm biology to drug development - can a new approach be developed?

Authors:  Thomas Bjarnsholt; Oana Ciofu; Søren Molin; Michael Givskov; Niels Høiby
Journal:  Nat Rev Drug Discov       Date:  2013-10       Impact factor: 84.694

2.  Antibiofilm Activities of a Novel Chimeolysin against Streptococcus mutans under Physiological and Cariogenic Conditions.

Authors:  Hang Yang; Yongli Bi; Xiaoran Shang; Mengyue Wang; Sara B Linden; Yunpeng Li; Yuhong Li; Daniel C Nelson; Hongping Wei
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  Bacteriophage Lysin CF-301, a Potent Antistaphylococcal Biofilm Agent.

Authors:  Raymond Schuch; Babar K Khan; Assaf Raz; Jimmy A Rotolo; Michael Wittekind
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 4.  Panel 4: Report of the Microbiology Panel.

Authors:  Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

5.  N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Nontypeable Haemophilus influenzae.

Authors:  Mirian Domenech; Ernesto García
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 6.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

7.  Biofilm-degrading enzymes from Lysobacter gummosus.

Authors:  Anke Gökçen; Andreas Vilcinskas; Jochen Wiesner
Journal:  Virulence       Date:  2014-02-11       Impact factor: 5.882

8.  Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract.

Authors:  Bruno Corsini; Roberto Díez-Martínez; Leire Aguinagalde; Fernando González-Camacho; Esther García-Fernández; Patricia Letrado; Pedro García; Jose Yuste
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

Review 9.  Ways to control harmful biofilms: prevention, inhibition, and eradication.

Authors:  Wen Yin; Siyang Xu; Yiting Wang; Yuling Zhang; Shan-Ho Chou; Michael Y Galperin; Jin He
Journal:  Crit Rev Microbiol       Date:  2020-12-28       Impact factor: 7.624

10.  Lysogenic conversion and phage resistance development in phage exposed Escherichia coli biofilms.

Authors:  Pieter Moons; David Faster; Abram Aertsen
Journal:  Viruses       Date:  2013-01-11       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.